Scale-down devices (SDD) are designed to simulate large-scale thawing of protein drug substance, but require only a fraction of the material. To evaluate the performance of a new SDD that aims to predict thawing in large-scale 2 L bottles, we characterised 3D temperature profiles and changes in concentration and density in comparison to 125 mL and 2 L bottles. Differences in diffusion between a monoclonal antibody (mAb) and histidine buffer after thawing were examined.Temperature profiles at six distinct positions were recorded with type T thermocouples. Size-exclusion chromatography allowed quantification of mAb and histidine. Polysorbate 80 was quantified using a fluorescent dye assay. In addition, the solution's density at different loca...
We examined the impact of monoclonal antibody (mAb) and buffer concentration, mimicking the cryoconc...
The early-stage assessment of the physical stability of new monoclonal antibodies in different formu...
Formulation of monoclonal antibody (mAb) solutions using membrane filtration processing is a critica...
PURPOSE Scale-down devices (SDD) are designed to simulate large-scale thawing of protein drug substa...
PURPOSE Scale-down devices (SDD) are designed to simulate large-scale thawing of protein drug substa...
PURPOSE Scale-down devices (SDD) are designed to simulate large-scale thawing of protein drug substa...
PURPOSE Scale-down devices (SDD) are designed to simulate large-scale thawing of protein drug substa...
There is a need for representative small volume devices that reflect monoclonal antibody (mAb) aggre...
Large-scale freezing and thawing experiments of monoclonal antibody (mAb) solutions are time and mat...
For transport logistical reasons and for the decoupling of DS and DP shelf-life, most Biologics Bulk...
Cryoconcentration of an in-house IgG1 and number of aggregates in a formulation containing trehalose...
Cryoconcentration of an in-house IgG1 and number of aggregates in a formulation containing trehalose...
Therapeutic proteins or biopharmaceuticals have been playing an ever-increasing role in the treatmen...
Purpose: This study addresses the effect of freezing and thawing on a therapeutic monoclonal antibod...
Cryoconcentration upon large-scale freezing of monoclonal antibody (mAb) solutions leads to regions ...
We examined the impact of monoclonal antibody (mAb) and buffer concentration, mimicking the cryoconc...
The early-stage assessment of the physical stability of new monoclonal antibodies in different formu...
Formulation of monoclonal antibody (mAb) solutions using membrane filtration processing is a critica...
PURPOSE Scale-down devices (SDD) are designed to simulate large-scale thawing of protein drug substa...
PURPOSE Scale-down devices (SDD) are designed to simulate large-scale thawing of protein drug substa...
PURPOSE Scale-down devices (SDD) are designed to simulate large-scale thawing of protein drug substa...
PURPOSE Scale-down devices (SDD) are designed to simulate large-scale thawing of protein drug substa...
There is a need for representative small volume devices that reflect monoclonal antibody (mAb) aggre...
Large-scale freezing and thawing experiments of monoclonal antibody (mAb) solutions are time and mat...
For transport logistical reasons and for the decoupling of DS and DP shelf-life, most Biologics Bulk...
Cryoconcentration of an in-house IgG1 and number of aggregates in a formulation containing trehalose...
Cryoconcentration of an in-house IgG1 and number of aggregates in a formulation containing trehalose...
Therapeutic proteins or biopharmaceuticals have been playing an ever-increasing role in the treatmen...
Purpose: This study addresses the effect of freezing and thawing on a therapeutic monoclonal antibod...
Cryoconcentration upon large-scale freezing of monoclonal antibody (mAb) solutions leads to regions ...
We examined the impact of monoclonal antibody (mAb) and buffer concentration, mimicking the cryoconc...
The early-stage assessment of the physical stability of new monoclonal antibodies in different formu...
Formulation of monoclonal antibody (mAb) solutions using membrane filtration processing is a critica...